Neurology Associates

Recent papers from Neurology Associates

1. Satisfaction of Biweekly Senofilcon A Toric Contact Lens Wearers Who Were Refit Into Weekly Serafilcon A Toric Contact LensesClinical Optometry · 2026
2. BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trialNature Medicine · 2026
3. BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trialNature Medicine · 2026
4. DOTATATE Scan in Meningiomatosis in a Patient With OphthalmoplegiaCase Reports in Ophthalmological Medicine · 2026
5. A Clinical Study Evaluating How Delefilcon A Contact Lenses Perform in Satisfied Senofilcon A Contact Lens WearersThe Open Ophthalmology Journal · 2025
6. To the Edge of the Fog: Location of Smart Fusion Nodes for Optimal Use of Communication Networks2025
7. Investigating the Effect of Reducing the Signs and Symptoms of Lid Wiper Epitheliopathy in Patients With Dry Eye Disease With PerfluorohexyloctaneCurrent Therapeutic Research · 2025
8. A Review on Medicinal and Ethnomedicinal Uses, Biological Features, and Phytochemical Constituents of Sesbania sesban L. Merr., A Nitrogen-Fixing Plant Native to the Republic of ChadThe Scientific World JOURNAL · 2024
9. Development of perioperative premature ventricular contractions as an indicator of splenic hemangiosarcoma and median survival timesVeterinary Surgery · 2021
10. System-Level Variation in Multiple Sclerosis Care Outcomes: Initial Findings from the Multiple Sclerosis Continuous Quality Improvement Research CollaborativePopulation Health Management · 2021
11. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1CThe Journal of Clinical Endocrinology & Metabolism · 2020
12. Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS StudiesNeurology and Therapy · 2020
13. Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical SettingsFrontiers in Neurology · 2019
14. Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 studyMultiple Sclerosis and Related Disorders · 2018
15. Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trialTherapeutic Advances in Neurological Disorders · 2018
16. Vasogenic Cerebral Edema following CT Myelogram with Nonionic Omnipaque 300Case Reports in Neurological Medicine · 2018
17. Natural history of muscle cramps in amyotrophic lateral sclerosisMuscle & Nerve · 2015
18. Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot StudyMultiple Sclerosis International · 2013
19. Effective Management of Construction Dispute ResolutionJournal of Legal Affairs and Dispute Resolution in Engineering and Construction · 2011
20. Neurocognitive Differential Diagnosis of Dementing Diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive DisorderInternational Journal of Neuroscience · 2006